Profiling mTOR pathway in neuroendocrine tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 183, doi. 10.1007/s11523-012-0226-9
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2012 AND VI 7 AND IP 3
Results: 9
1
2
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 173, doi. 10.1007/s11523-012-0229-6
- By:
- Publication type:
- Article
3
Inhibition of mTOR in carcinoid tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 189, doi. 10.1007/s11523-012-0225-x
- By:
- Publication type:
- Article
4
New treatment options with cytotoxic agents in neuroendocrine tumours.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 169, doi. 10.1007/s11523-012-0228-7
- By:
- Publication type:
- Article
5
Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 153, doi. 10.1007/s11523-012-0230-0
- By:
- Publication type:
- Article
6
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 199, doi. 10.1007/s11523-012-0227-8
- By:
- Publication type:
- Article
7
Streptozocin-based chemotherapy is not history in neuroendocrine tumours.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 3, p. 161, doi. 10.1007/s11523-012-0224-y
- By:
- Publication type:
- Article
8
Erratum to: Inhibition of mTOR in carcinoid tumors.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
9
Targeting neuroendocrine tumor: mixing standard options with novel therapies.
- Published in:
- 2012
- By:
- Publication type:
- Editorial